Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment

Por Ciucci, Alessandra, Zannoni, Gian Franco, Buttarelli, Marianna, Martinelli, Enrica, Mascilini, Floriana, Petrillo, Marco, Ferrandina, Gabriella, Scambia, Giovanni, Gallo, Daniela
Publicado no Oncotarget (2016)

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study

Por Ferrandina, Gabriella, Corrado, Giacomo, Mascilini, Floriana, Malaguti, Paola, Samaritani, Riccardo, Distefano, Mariagrazia, Masciullo, Valeria, Di Legge, Alessia, Savarese, Antonella, Scambia, Giovanni
Publicado no BMC Cancer (2014)

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence

Por Mascilini, Floriana, Amadio, Giulia, Di Stefano, Maria Grazia, Ludovisi, Manuela, Di Legge, Alessia, Conte, Carmine, De Vincenzo, Rosa, Ricci, Caterina, Masciullo, Valeria, Salutari, Vanda, Scambia, Giovanni, Ferrandina, Gabriella
Publicado em 2014